These findings provide a potential explanation for the frequently observed A+T− CSF profile in cognitively impaired individuals, which has spurred debate about whether such cases should be classified as AD,46 given that the biological definition of AD requires abnormal levels of both amyloid and tau.3 However, biomarkers and their cut‐offs may not always accurately reflect underlying pathology. This evidence concerns the gene MAPT and Alzheimer disease.